Palonosetron Associated to Aprepitant in Prophylaxis of PONV

NCT02431286 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Instituto do Cancer do Estado de São Paulo